Fair Value Disclosures (Tables)
|
9 Months Ended |
Aug. 31, 2019 |
Fair Value Disclosures [Abstract] |
|
Schedule Of Assets And Liabilities Measured On Recurring Basis At Fair Value |
The following is a summary of our financial instruments, securities purchased under agreements to resell, trading liabilities and long-term debt that are accounted for at fair value on a recurring basis, excluding Investments at fair value based on net asset value ("NAV") (within trading assets) of $573.5 million and $394.4 million at August 31, 2019 and November 30, 2018, respectively, by level within the fair value hierarchy (in thousands): | | | | | | | | | | | | | | | | | | | | | | August 31, 2019 | | Level 1 | | Level 2 | | Level 3 | | Counterparty and Cash Collateral Netting (1) | | Total | Assets: | | | | | | | | | | Trading assets, at fair value: | | | | | | | | | | Corporate equity securities | $ | 2,938,829 |
| | $ | 162,382 |
| | $ | 50,870 |
| | $ | — |
| | $ | 3,152,081 |
| Corporate debt securities | — |
| | 2,892,733 |
| | 9,288 |
| | — |
| | 2,902,021 |
| Collateralized debt obligations and collateralized loan obligations | — |
| | 114,045 |
| | 30,258 |
| | — |
| | 144,303 |
| U.S. government and federal agency securities | 2,115,452 |
| | 204,076 |
| | — |
| | — |
| | 2,319,528 |
| Municipal securities | — |
| | 723,542 |
| | — |
| | — |
| | 723,542 |
| Sovereign obligations | 1,521,540 |
| | 1,088,927 |
| | — |
| | — |
| | 2,610,467 |
| Residential mortgage-backed securities | — |
| | 1,405,246 |
| | 17,929 |
| | — |
| | 1,423,175 |
| Commercial mortgage-backed securities | — |
| | 373,319 |
| | 5,462 |
| | — |
| | 378,781 |
| Other asset-backed securities | — |
| | 490,055 |
| | 34,598 |
| | — |
| | 524,653 |
| Loans and other receivables | — |
| | 1,460,982 |
| | 75,563 |
| | — |
| | 1,536,545 |
| Derivatives | 10,587 |
| | 2,982,776 |
| | 16,024 |
| | (2,494,645 | ) | | 514,742 |
| Investments at fair value | — |
| | 41,548 |
| | 292,483 |
| | — |
| | 334,031 |
| FXCM term loan | — |
| | — |
| | 58,590 |
| | — |
| | 58,590 |
| Total trading assets, excluding investments at fair value based on NAV | $ | 6,586,408 |
|
| $ | 11,939,631 |
|
| $ | 591,065 |
|
| $ | (2,494,645 | ) |
| $ | 16,622,459 |
| Securities purchased under agreements to resell | $ | — |
| | $ | — |
| | $ | 25,000 |
| | $ | — |
| | $ | 25,000 |
| | | | | | | | | | | Liabilities: | |
| | |
| | |
| | |
| | |
| Trading liabilities: | |
| | |
| | |
| | |
| | |
| Corporate equity securities | $ | 2,750,131 |
| | $ | 7,097 |
| | $ | 211 |
| | $ | — |
| | $ | 2,757,439 |
| Corporate debt securities | — |
| | 1,803,666 |
| | 1,202 |
| | — |
| | 1,804,868 |
| U.S. government and federal agency securities | 1,922,145 |
| | — |
| | — |
| | — |
| | 1,922,145 |
| Sovereign obligations | 1,281,332 |
| | 853,882 |
| | — |
| | — |
| | 2,135,214 |
| Commercial mortgage-backed securities | — |
| | — |
| | 35 |
| | — |
| | 35 |
| Loans | — |
| | 1,097,178 |
| | 16,630 |
| | — |
| | 1,113,808 |
| Derivatives | 7,327 |
| | 3,088,068 |
| | 66,787 |
| | (2,599,376 | ) | | 562,806 |
| Total trading liabilities | $ | 5,960,935 |
|
| $ | 6,849,891 |
|
| $ | 84,865 |
|
| $ | (2,599,376 | ) |
| $ | 10,296,315 |
| Long-term debt | $ | — |
| | $ | 666,446 |
| | $ | 348,063 |
| | $ | — |
| | $ | 1,014,509 |
|
| | | | | | | | | | | | | | | | | | | | | | November 30, 2018 | | Level 1 | | Level 2 | | Level 3 | | Counterparty and Cash Collateral Netting (1) | | Total | Assets: | | | | | | | | | | Trading assets, at fair value: | | | | | | | | | | Corporate equity securities | $ | 2,497,045 |
| | $ | 118,681 |
| | $ | 52,192 |
| | $ | — |
| | $ | 2,667,918 |
| Corporate debt securities | — |
| | 2,683,180 |
| | 9,484 |
| | — |
| | 2,692,664 |
| Collateralized debt obligations and collateralized loan obligations | — |
| | 72,949 |
| | 36,105 |
| | — |
| | 109,054 |
| U.S. government and federal agency securities | 1,789,614 |
| | 56,592 |
| | — |
| | — |
| | 1,846,206 |
| Municipal securities | — |
| | 894,253 |
| | — |
| | — |
| | 894,253 |
| Sovereign obligations | 1,769,556 |
| | 1,043,409 |
| | — |
| | — |
| | 2,812,965 |
| Residential mortgage-backed securities | — |
| | 2,163,629 |
| | 19,603 |
| | — |
| | 2,183,232 |
| Commercial mortgage-backed securities | — |
| | 819,406 |
| | 10,886 |
| | — |
| | 830,292 |
| Other asset-backed securities | — |
| | 239,381 |
| | 53,175 |
| | — |
| | 292,556 |
| Loans and other receivables | — |
| | 2,056,593 |
| | 46,985 |
| | — |
| | 2,103,578 |
| Derivatives | 34,841 |
| | 2,539,943 |
| | 5,922 |
| | (2,413,931 | ) | | 166,775 |
| Investments at fair value | — |
| | — |
| | 396,254 |
| | — |
| | 396,254 |
| FXCM term loan | — |
| | — |
| | 73,150 |
| | — |
| | 73,150 |
| Total trading assets, excluding investments at fair value based on NAV | $ | 6,091,056 |
|
| $ | 12,688,016 |
|
| $ | 703,756 |
|
| $ | (2,413,931 | ) |
| $ | 17,068,897 |
| | | | | | | | | | | Available for sale securities: | |
| | |
| | |
| | |
| | |
| U.S. government securities | $ | 1,072,856 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 1,072,856 |
| Residential mortgage-backed securities | — |
| | 210,518 |
| | — |
| | — |
| | 210,518 |
| Commercial mortgage-backed securities | — |
| | 15,642 |
| | — |
| | — |
| | 15,642 |
| Other asset-backed securities | — |
| | 110,870 |
| | — |
| | — |
| | 110,870 |
| Total available for sale securities | $ | 1,072,856 |
|
| $ | 337,030 |
|
| $ | — |
|
| $ | — |
|
| $ | 1,409,886 |
| | | | | | | | | | | Liabilities: | |
| | |
| | |
| | |
| | |
| Trading liabilities: | |
| | |
| | |
| | |
| | |
| Corporate equity securities | $ | 1,685,071 |
| | $ | 1,444 |
| | $ | — |
| | $ | — |
| | $ | 1,686,515 |
| Corporate debt securities | — |
| | 1,505,618 |
| | 522 |
| | — |
| | 1,506,140 |
| U.S. government and federal agency securities | 1,384,295 |
| | — |
| | — |
| | — |
| | 1,384,295 |
| Sovereign obligations | 1,735,242 |
| | 661,095 |
| | — |
| | — |
| | 2,396,337 |
| Loans | — |
| | 1,371,630 |
| | 6,376 |
| | — |
| | 1,378,006 |
| Derivatives | 26,473 |
| | 3,586,694 |
| | 27,536 |
| | (2,513,050 | ) | | 1,127,653 |
| Total trading liabilities | $ | 4,831,081 |
|
| $ | 7,126,481 |
|
| $ | 34,434 |
|
| $ | (2,513,050 | ) |
| $ | 9,478,946 |
| Long-term debt | $ | — |
| | $ | 485,425 |
| | $ | 200,745 |
| | $ | — |
| | $ | 686,170 |
|
(1) Represents counterparty and cash collateral netting across the levels of the fair value hierarchy for positions with the same counterparty.
|
Investments Measured At Fair Value Based On Net Asset Value |
The following tables present information about our investments in entities that have the characteristics of an investment company (in thousands): | | | | | | | | | | Fair Value (1) | | Unfunded Commitments | August 31, 2019 | | | | Equity Long/Short Hedge Funds (2) | $ | 292,205 |
| | $ | — |
| Equity Funds (3) | 33,891 |
| | 19,154 |
| Commodity Funds (4) | 15,212 |
| | — |
| Multi-asset Funds (5) | 231,991 |
| | — |
| Other Funds (6) | 158 |
| | — |
| Total | $ | 573,457 |
| | $ | 19,154 |
| | | | | November 30, 2018 | |
| | |
| Equity Long/Short Hedge Funds (2) | $ | 86,788 |
| | $ | — |
| Equity Funds (3) | 40,070 |
| | 20,996 |
| Commodity Funds (4) | 10,129 |
| | — |
| Multi-asset Funds (5) | 256,972 |
| | — |
| Other Funds (6) | 400 |
| | — |
| Total | $ | 394,359 |
| | $ | 20,996 |
|
| | (1) | Where fair value is calculated based on NAV, fair value has been derived from each of the funds' capital statements. |
| | (2) | This category includes investments in hedge funds that invest, long and short, primarily in equity securities in domestic and international markets in both the public and private sectors. At August 31, 2019 and November 30, 2018, approximately 94% and 0%, respectively, of the fair value of investments in this category cannot be redeemed because these investments include restrictions that do not allow for redemption in the first 36 months after acquisition. At August 31, 2019 and November 30, 2018, 6% and 17%, respectively, of these investments are redeemable quarterly with 60 days prior written notice. Approximately 82% of the November 30, 2018 balance was redeemed during the nine months ended August 31, 2019. |
| | (3) | The investments in this category include investments in equity funds that invest in the equity of various U.S. and foreign private companies in the energy, technology, internet service and telecommunication service industries. These investments cannot be redeemed; instead distributions are received through the liquidation of the underlying assets of the funds, which are expected to be liquidated in approximately one to nine years. |
| | (4) | This category includes investments in a hedge fund that invests, long and short, primarily in commodities. Investments in this category are redeemable quarterly with 60 days prior written notice. |
| | (5) | This category includes investments in hedge funds that invest, long and short, primarily in multi-asset securities in domestic and international markets in both the public and private sectors. At August 31, 2019 and November 30, 2018, investments representing approximately 4% and 15%, respectively, of the fair value of investments in this category are redeemable monthly with 30 days prior written notice. |
(6) This category includes investments in a fund that invests in loans secured by a first trust deed on property, domestic and international public high yield debt, private high yield investments, senior bank loans, public leveraged equities, distressed debt and private equity investments and there are no redemption provisions. This category also includes investments in a fund of funds that invests in various private equity funds that are managed by Jefferies Group and have no redemption provisions. Investments in the fund of funds are gradually being liquidated, however, the timing of when the proceeds will be received is uncertain.
|
Summary Of Changes In Fair Value Of Financial Assets And Liabilities Classified As Level 3 |
The following is a summary of changes in fair value of our financial assets and liabilities that have been categorized within Level 3 of the fair value hierarchy for the three months ended August 31, 2019 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended August 31, 2019 | | Balance, May 31, 2019 | | Total gains/ losses (realized and unrealized) (1) | | Purchases | | Sales | | Settlements | | Issuances | | Net transfers into (out of) Level 3 | | Balance, August 31, 2019 | | Changes in unrealized gains/losses included in earnings relating to instruments still held at August 31, 2019 (1) | Assets: | | | | | | | | | | | | | | | | | | Trading assets: | | | | | | | | | | | | | | | | | | Corporate equity securities | $ | 59,572 |
| | $ | 12,547 |
| | $ | 16,508 |
| | $ | (17,502 | ) | | $ | — |
| | $ | — |
| | $ | (20,255 | ) | | $ | 50,870 |
| | $ | 12,067 |
| Corporate debt securities | 8,346 |
| | (3,072 | ) | | 1,175 |
| | (1,942 | ) | | (85 | ) | | — |
| | 4,866 |
| | 9,288 |
| | (3,047 | ) | CDOs and CLOs | 25,912 |
| | (1,499 | ) | | — |
| | — |
| | (609 | ) | | — |
| | 6,454 |
| | 30,258 |
| | (2,097 | ) | Residential mortgage-backed securities | 17,266 |
| | (1,917 | ) | | — |
| | (65 | ) | | (22 | ) | | — |
| | 2,667 |
| | 17,929 |
| | (1,435 | ) | Commercial mortgage-backed securities | 12,530 |
| | (2,003 | ) | | — |
| | (1,703 | ) | | (3,362 | ) | | — |
| | — |
| | 5,462 |
| | (3,143 | ) | Other asset-backed securities | 43,185 |
| | (1,689 | ) | | 13,497 |
| | (6,975 | ) | | (5,500 | ) | | — |
| | (7,920 | ) | | 34,598 |
| | (1,068 | ) | Loans and other receivables | 98,484 |
| | (2,847 | ) | | 26,921 |
| | (33,409 | ) | | (1,287 | ) | | — |
| | (12,299 | ) | | 75,563 |
| | (2,392 | ) | Investments at fair value | 408,739 |
| | (152,162 | ) | | 1,067 |
| | (296 | ) | | — |
| | — |
| | 35,135 |
| | 292,483 |
| | (152,162 | ) | FXCM term loan | 56,600 |
| | 2,293 |
| | — |
| | — |
| | (303 | ) | | — |
| | — |
| | 58,590 |
| | 2,293 |
| Securities purchased under agreements to resell | 25,000 |
| | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | 25,000 |
| | — |
| | | | | | | | | | | | | | | | | | | Liabilities: | |
| | | | |
| | |
| | |
| | |
| | |
| | |
| | |
| Trading liabilities: | |
| | | | |
| | |
| | |
| | |
| | |
| | |
| | |
| Corporate equity securities | $ | 221 |
| | $ | 401 |
| | $ | (221 | ) | | $ | — |
| | $ | (190 | ) | | $ | — |
| | $ | — |
| | $ | 211 |
| | $ | (35 | ) | Corporate debt securities | 669 |
| | (650 | ) | | (34 | ) | | — |
| | (369 | ) | | — |
| | 1,586 |
| | 1,202 |
| | 649 |
| Commercial mortgage-backed securities | — |
| | — |
| | — |
| | 35 |
| | — |
| | — |
| | — |
| | 35 |
| | — |
| Loans | 9,428 |
| | (520 | ) | | (10,281 | ) | | 5,384 |
| | — |
| | — |
| | 12,619 |
| | 16,630 |
| | 531 |
| Net derivatives (2) | 47,449 |
| | (19,519 | ) | | — |
| | 6,766 |
| | (14 | ) | | — |
| | 16,081 |
| | 50,763 |
| | 18,507 |
| Long-term debt (1) | 236,562 |
| | 7,455 |
| | — |
| | — |
| | — |
| | 114,641 |
| | (10,595 | ) | | 348,063 |
| | (8,162 | ) |
| | (1) | Realized and unrealized gains (losses) are primarily reported in Principal transactions revenues in the Consolidated Statements of Operations. Changes in instrument-specific credit risk related to structured notes are included in our Consolidated Statements of Comprehensive Income (Loss), net of tax. Changes in unrealized gains (losses) included in other comprehensive income (loss) for instruments still held at August 31, 2019 were gains of $0.7 million. |
(2) Net derivatives represent Trading assets - Derivatives and Trading liabilities - Derivatives. The following is a summary of changes in fair value of our financial assets and liabilities that have been categorized within Level 3 of the fair value hierarchy for the three months ended September 30, 2018 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, 2018 | | Balance, June 30, 2018 | | Total gains/ losses (realized and unrealized) (1) | | Purchases | | Sales | | Settlements | | Issuances | | Net transfers into (out of) Level 3 | | Balance, September 30, 2018 | | Changes in unrealized gains/ losses relating to instruments still held at September 30, 2018 (1) | Assets: | | | | | | | | | | | | | | | | | | Trading assets: | | | | | | | | | | | | | | | | | | Corporate equity securities | $ | 44,871 |
| | $ | 11,796 |
| | $ | 17,652 |
| | $ | (23,010 | ) | | $ | (302 | ) | | $ | — |
| | $ | (1,324 | ) | | $ | 49,683 |
| | $ | 9,136 |
| Corporate debt securities | 28,066 |
| | 1,057 |
| | 507 |
| | (21,403 | ) | | (59 | ) | | — |
| | 1,483 |
| | 9,651 |
| | (165 | ) | CDOs and CLOs | 42,517 |
| | (967 | ) | | 238,281 |
| | (240,002 | ) | | (2,127 | ) | | — |
| | (3,721 | ) | | 33,981 |
| | (3,872 | ) | Residential mortgage-backed securities | 3,655 |
| | (66 | ) | | 72 |
| | (1,597 | ) | | (1 | ) | | — |
| | 2,891 |
| | 4,954 |
| | 90 |
| Commercial mortgage-backed securities | 27,239 |
| | (222 | ) | | 8 |
| | — |
| | (1,156 | ) | | — |
| | (1,953 | ) | | 23,916 |
| | (288 | ) | Other asset-backed securities | 55,535 |
| | (2,269 | ) | | 307,358 |
| | (290,838 | ) | | (4,356 | ) | | — |
| | 3,875 |
| | 69,305 |
| | (1,124 | ) | Loans and other receivables | 64,036 |
| | (1,353 | ) | | 14,932 |
| | (23,700 | ) | | (3,453 | ) | | — |
| | (1,477 | ) | | 48,985 |
| | 1,007 |
| Investments at fair value | 318,543 |
| | 2,383 |
| | 6,051 |
| | — |
| | — |
| | — |
| | — |
| | 326,977 |
| | 2,383 |
| FXCM term loan | 76,100 |
| | 1,347 |
| | — |
| | — |
| | (3,647 | ) | | — |
| | — |
| | 73,800 |
| | (2,300 | ) | Liabilities: | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| Trading liabilities: | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| Corporate equity securities | $ | 87 |
| | $ | 326 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 413 |
| | $ | (326 | ) | Corporate debt securities | 522 |
| | 39 |
| | — |
| | — |
| | 996 |
| | — |
| | — |
| | 1,557 |
| | (39 | ) | Sovereign obligations | — |
| | 3 |
| | (598 | ) | | 629 |
| | — |
| | — |
| | 21 |
| | 55 |
| | (124 | ) | Commercial mortgage-backed securities | — |
| | 70 |
| | — |
| | — |
| | — |
| | — |
| | — |
| | 70 |
| | (70 | ) | Loans | 12,881 |
| | (148 | ) | | (4,871 | ) | | 1,787 |
| | — |
| | — |
| | (988 | ) | | 8,661 |
| | 149 |
| Net derivatives (2) | 5,874 |
| | 1,107 |
| | — |
| | — |
| | 1,990 |
| | — |
| | 26 |
| | 8,997 |
| | (2,090 | ) | Long-term debt (1) | 160,626 |
| | 3,004 |
| | — |
| | — |
| | — |
| | — |
| | — |
| | 163,630 |
| | (2,953 | ) |
| | (1) | Realized and unrealized gains (losses) are primarily reported in Principal transactions revenues in the Consolidated Statements of Operations. Changes in instrument-specific credit risk related to structured notes are included in our Consolidated Statements of Comprehensive Income (Loss), net of tax. Changes in unrealized gains (losses) included in other comprehensive income (loss) for instruments still held at September 30, 2018 were losses of $0.1 million. |
(2) Net derivatives represent Trading assets - Derivatives and Trading liabilities - Derivatives. The following is a summary of changes in fair value of our financial assets and liabilities that have been categorized within Level 3 of the fair value hierarchy for the nine months ended September 30, 2018 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Nine Months Ended September 30, 2018 | | Balance, December 31, 2017 | | Total gains/ losses (realized and unrealized) (1) | | Purchases | | Sales | | Settlements | | Issuances | | Net transfers into (out of) Level 3 | | Balance, September 30, 2018 | | Changes in unrealized gains/ losses relating to instruments still held at September 30, 2018 (1) | Assets: | | | | | | | | | | | | | | | | | | Trading assets: | | | | | | | | | | | | | | | | | | Corporate equity securities | $ | 22,270 |
| | $ | 31,475 |
| | $ | 35,993 |
| | $ | (39,008 | ) | | $ | (2,082 | ) | | $ | — |
| | $ | 1,035 |
| | $ | 49,683 |
| | $ | 26,852 |
| Corporate debt securities | 26,036 |
| | 1,090 |
| | 22,204 |
| | (38,553 | ) | | (2,066 | ) | | — |
| | 940 |
| | 9,651 |
| | (1,738 | ) | CDOs and CLOs | 42,184 |
| | (4,123 | ) | | 242,864 |
| | (249,691 | ) | | (5,859 | ) | | — |
| | 8,606 |
| | 33,981 |
| | (7,333 | ) | Residential mortgage-backed securities | 26,077 |
| | (7,334 | ) | | 2,018 |
| | (12,621 | ) | | (6 | ) | | — |
| | (3,180 | ) | | 4,954 |
| | 316 |
| Commercial mortgage-backed securities | 12,419 |
| | (1,236 | ) | | 1,720 |
| | (548 | ) | | (5,415 | ) | | — |
| | 16,976 |
| | 23,916 |
| | (2,272 | ) | Other asset-backed securities | 61,129 |
| | (7,528 | ) | | 523,045 |
| | (495,055 | ) | | (12,281 | ) | | — |
| | (5 | ) | | 69,305 |
| | (3,307 | ) | Loans and other receivables | 47,304 |
| | (2,812 | ) | | 104,009 |
| | (98,733 | ) | | (14,610 | ) | | — |
| | 13,827 |
| | 48,985 |
| | (3,769 | ) | Investments at fair value | 329,944 |
| | 3,865 |
| | 9,791 |
| | (17,569 | ) | | — |
| | — |
| | 946 |
| | 326,977 |
| | 3,271 |
| FXCM term loan | 72,800 |
| | 16,432 |
| | — |
| | — |
| | (15,432 | ) | | — |
| | — |
| | 73,800 |
| | 5,539 |
| Liabilities: | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| Trading liabilities: | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| Corporate equity securities | $ | 48 |
| | $ | 365 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 413 |
| | $ | (365 | ) | Corporate debt securities | 522 |
| | 39 |
| | — |
| | — |
| | 996 |
| | — |
| | — |
| | 1,557 |
| | (39 | ) | Sovereign obligations | — |
| | 3 |
| | (598 | ) | | 629 |
| | — |
| | — |
| | 21 |
| | 55 |
| | (124 | ) | Commercial mortgage-backed securities | 105 |
| | (35 | ) | | — |
| | — |
| | — |
| | — |
| | — |
| | 70 |
| | (70 | ) | Loans | 3,486 |
| | (1,059 | ) | | (15,702 | ) | | 19,409 |
| | — |
| | — |
| | 2,527 |
| | 8,661 |
| | 1,059 |
| Net derivatives (2) | 6,746 |
| | (1,034 | ) | | (6 | ) | | — |
| | 2,984 |
| | 296 |
| | 11 |
| | 8,997 |
| | (2,660 | ) | Long-term debt (1) | — |
| | (25,078 | ) | | — |
| | — |
| | — |
| | 81,284 |
| | 107,424 |
| | 163,630 |
| | 13,235 |
|
| | (1) | Realized and unrealized gains (losses) are primarily reported in Principal transactions revenues in the Consolidated Statements of Operations. Changes in instrument-specific credit risk related to structured notes are included in our Consolidated Statements of Comprehensive Income (Loss), net of tax. Changes in unrealized gains (losses) included in other comprehensive income (loss) for instruments still held at September 30, 2018 were gains of $11.8 million. |
(2) Net derivatives represent Trading assets - Derivatives and Trading liabilities - Derivatives. The following is a summary of changes in fair value of our financial assets and liabilities that have been categorized within Level 3 of the fair value hierarchy for the nine months ended August 31, 2019 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Nine Months Ended August 31, 2019 | | Balance, November 30, 2018 | | Total gains/ losses (realized and unrealized) (1) | | Purchases | | Sales | | Settlements | | Issuances | | Net transfers into (out of) Level 3 | | Balance, August 31, 2019 | | Changes in unrealized gains/losses included in earnings relating to instruments still held at August 31, 2019 (1) | Assets: | | | | | | | | | | | | | | | | | | Trading assets: | | | | | | | | | | | | | | | | | | Corporate equity securities | $ | 52,192 |
| | $ | 15,499 |
| | $ | 23,172 |
| | $ | (25,431 | ) | | $ | (669 | ) | | $ | — |
| | $ | (13,893 | ) | | $ | 50,870 |
| | $ | 14,071 |
| Corporate debt securities | 9,484 |
| | (4,904 | ) | | 6,080 |
| | (10,544 | ) | | (553 | ) | | — |
| | 9,725 |
| | 9,288 |
| | (5,325 | ) | CDOs and CLOs | 36,105 |
| | (4,320 | ) | | 48,112 |
| | (43,230 | ) | | (3,014 | ) | | — |
| | (3,395 | ) | | 30,258 |
| | (6,781 | ) | Residential mortgage-backed securities | 19,603 |
| | (2,573 | ) | | 2,166 |
| | (2,022 | ) | | (171 | ) | | — |
| | 926 |
| | 17,929 |
| | (2,166 | ) | Commercial mortgage-backed securities | 10,886 |
| | (2,196 | ) | | 11 |
| | (2,023 | ) | | (6,638 | ) | | — |
| | 5,422 |
| | 5,462 |
| | (4,326 | ) | Other asset-backed securities | 53,175 |
| | (929 | ) | | 14,698 |
| | (2,494 | ) | | (30,623 | ) | | — |
| | 771 |
| | 34,598 |
| | (961 | ) | Loans and other receivables | 46,985 |
| | 3,933 |
| | 178,069 |
| | (166,496 | ) | | (8,379 | ) | | — |
| | 21,451 |
| | 75,563 |
| | 682 |
| Investments at fair value | 396,254 |
| | (119,110 | ) | | 42,579 |
| | (18,598 | ) | | — |
| | — |
| | (8,642 | ) | | 292,483 |
| | (119,110 | ) | FXCM term loan | 73,150 |
| | (8,669 | ) | | 1,500 |
| | — |
| | (7,391 | ) | | — |
| | — |
| | 58,590 |
| | (8,669 | ) | Securities purchased under agreements to resell | — |
| | — |
| | — |
| | — |
| | — |
| | 25,000 |
| | — |
| | 25,000 |
| | — |
| | | | | | | | | | | | | | | | | | | Liabilities: | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| Trading liabilities: | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| Corporate equity securities | $ | — |
| | $ | 401 |
| | $ | — |
| | $ | — |
| | $ | (190 | ) | | $ | — |
| | $ | — |
| | $ | 211 |
| | $ | (35 | ) | Corporate debt securities | 522 |
| | (867 | ) | | — |
| | — |
| | (524 | ) | | — |
| | 2,071 |
| | 1,202 |
| | 867 |
| Commercial mortgage-backed securities | — |
| | — |
| | — |
| | 35 |
| | — |
| | — |
| | — |
| | 35 |
| | — |
| Loans | 6,376 |
| | (1,342 | ) | | (8,553 | ) | | 9,929 |
| | — |
| | — |
| | 10,220 |
| | 16,630 |
| | 1,583 |
| Net derivatives (2) | 21,614 |
| | (48,746 | ) | | (2,829 | ) | | 16,313 |
| | 1,609 |
| | — |
| | 62,802 |
| | 50,763 |
| | 40,052 |
| Long-term debt (1) | 200,745 |
| | (5,286 | ) | | — |
| | — |
| | (11,250 | ) | | 204,710 |
| | (40,856 | ) | | 348,063 |
| | (4,517 | ) |
| | (1) | Realized and unrealized gains (losses) are primarily reported in Principal transactions revenues in the Consolidated Statements of Operations. Changes in instrument-specific credit risk related to structured notes are included in our Consolidated Statements of Comprehensive Income (Loss), net of tax. Changes in unrealized gains (losses) included in other comprehensive income (loss) for instruments still held at August 31, 2019 were gains of $9.8 million. |
(2) Net derivatives represent Trading assets - Derivatives and Trading liabilities - Derivatives.
|
Quantitative Information About Significant Unobservable Inputs Used In Level 3 Fair Value Measurements |
The tables below present information on the valuation techniques, significant unobservable inputs and their ranges for our financial assets and liabilities, subject to threshold levels related to the market value of the positions held, measured at fair value on a recurring basis with a significant Level 3 balance. The range of unobservable inputs could differ significantly across different firms given the range of products across different firms in the financial services sector. The inputs are not representative of the inputs that could have been used in the valuation of any one financial instrument (i.e., the input used for valuing one financial instrument within a particular class of financial instruments may not be appropriate for valuing other financial instruments within that given class). Additionally, the ranges of inputs presented below should not be construed to represent uncertainty regarding the fair values of our financial instruments; rather, the range of inputs is reflective of the differences in the underlying characteristics of the financial instruments in each category.
For certain categories, we have provided a weighted average of the inputs allocated based on the fair values of the financial instruments comprising the category. We do not believe that the range or weighted average of the inputs is indicative of the reasonableness of uncertainty of our Level 3 fair values. The range and weighted average are driven by the individual financial instruments within each category and their relative distribution in the population. The disclosed inputs when compared with the inputs as disclosed in other periods should not be expected to necessarily be indicative of changes in our estimates of unobservable inputs for a particular financial instrument as the population of financial instruments comprising the category will vary from period to period based on purchases and sales of financial instruments during the period as well as transfers into and out of Level 3 each period. | | | | | | | | | | | | | | | August 31, 2019 | Financial Instruments Owned | | Fair Value (in thousands) | | Valuation Technique | | Significant Unobservable Input(s) | | Input/Range | | Weighted Average | Corporate equity securities | | $ | 45,344 |
| | | | | | | | | Non-exchange-traded securities | | |
| | Market approach | | Price | | $3 to $177 | | $143 | | | | |
| | Underlying stock price | | $3 to $5 | | $4 | | | | | | | | | | | | Corporate debt securities | | $ | 9,288 |
| | Scenario analysis | | Estimated recovery percentage | | 38% to 49% | | 42 | % | | | | |
| | Volatility | | 44% | | — |
| | | | | | | Credit spread | | 750 | | — |
| | | | | | | Underlying stock price | | £0.4 | | — |
| | | | | | | | | | | | CDOs and CLOs | | $ | 30,258 |
| | Discounted cash flows | | Constant prepayment rate | | 15% to 20% | | 19 | % | | | |
| | | | Constant default rate | | 1% to 2% | | 2 | % | | | |
| | | | Loss severity | | 25% to 30% | | 27 | % | | | |
| | | | Discount rate/yield | | 13% to 16% | | 14 | % | | | | | Scenario analysis | | Estimated recovery percentage | | 4% to 37% | | 26 | % | | | | | | | | | | | | Residential mortgage-backed securities | | $ | 17,929 |
| | Discounted cash flows | | Cumulative loss rate | | 2% | | — |
| | | |
| | | | Duration (years) | | 7 years | | — |
| | | |
| | | | Discount rate/yield | | 3% | | — |
| | | | | | | | | | | | Commercial mortgage-backed securities | | $ | 5,462 |
| | Discounted cash flows | | Cumulative loss rate | | 80% | | — |
| | | |
| | | | Duration (years) | | 1 year | | — |
| | | | | | | Discount rate/yield | | 5% | | — |
| | | | | Scenario analysis | | Estimated recovery percentage | | 44% | | — |
| | | | | | | | | | | | Other asset-backed securities | | $ | 34,598 |
| | Discounted cash flows | | Cumulative loss rate | | 7% to 31% | | 18 | % | | | |
| | | | Duration (years) | | 1 year to 3 years | | 2 years | | | |
| | | | Discount rate/yield | | 7% to 12% | | 11 | % | | | | | | | | | | | | Loans and other receivables | | $ | 74,057 |
| | Market approach | | Price | | $41 to $100 | | $81 | | | |
| | Scenario analysis | | Estimated recovery percentage | | 1% to 117% | | 68 | % | | | | | | | | | | | | Derivatives | | $ | 13,538 |
| | | | | | | | |
| Interest rate swaps | | | | Market approach | | Basis points upfront | | 0 to 7 | | 3 |
| | | | | | | | | | | | Investments at fair value | | $ | 229,586 |
| | | | | | | | |
| Private equity securities | | | | Market approach | | Price | | $8 to $250 | | $125 | | | | | Scenario analysis | | Discount rate/yield | | 20% | | — |
| | | | | | | Revenue growth | | 0% | | — |
| | | | | Market approach | | Price | | $38 | | — |
| | | | | | | | | | | | | | | | | | | | | | | Investment in FXCM | | $ | 58,590 |
| | | | | | | | |
| Term loan | | | | Discounted cash flows | | Term based on the pay off (years) | | 0 months to 1.5 years | | 1.5 years | | | | | | | | | | | | Securities purchased under agreements to resell | | $ | 25,000 |
| | Market approach | | Spread to 6 month LIBOR | | 500 | | — |
| | | | | | | Duration (years) | | 2 years | | — |
| | |
| | | | | | | | | Trading Liabilities | | | | | | | | | | | Loans | | $ | 16,630 |
| | Market approach | | Price | | $50 to $98 | | $78 | | | | | Scenario analysis | | Estimated recovery percentage | | 1% to 75% | | 27 | % | | | | | | | | | | | | Derivatives | | $ | 65,927 |
| | | | | | | | |
| Equity options | | | | Volatility benchmarking | | Volatility | | 29% to 59% | | 42 | % | Interest rate swaps | | | | Market approach | | Basis points upfront | | 0 to 10 | | 4 |
| Cross currency swaps | | | | | | Basis points upfront | | 2 | | — |
| Unfunded commitments | | | | | | Price | | $90 | | — |
| | | | | | | | | | | | Long-term debt | | $ | 348,063 |
| | | | | | | | |
| Structured notes | | | | Market approach | | Price | | $89 to $102 | | $97 | | | | | | | Price | | €70 to €103 | | €89 |
| | | | | | | | | | | | | | | November 30, 2018 | Financial Instruments Owned | | Fair Value (in thousands) | | Valuation Technique | | Significant Unobservable Input(s) | | Input/Range | | Weighted Average | Corporate equity securities | | $ | 43,644 |
| | | | | | | | | Non-exchange-traded securities | | | | Market approach | | Price | | $1 to $75 | | $12 | | | | | | | Transaction level | | $47 | | — |
| | | | | | | | | | | | Corporate debt securities | | $ | 9,484 |
| | Market approach | | Estimated recovery percentage | | 46% | | — |
| | | | | | | Transaction level | | $80 | | — |
| | | | | | | | | | | | CDOs and CLOs | | $ | 36,105 |
| | Discounted cash flows | | Constant prepayment rate | | 10% to 20% | | 18 | % | | | |
| | | | Constant default rate | | 1% to 2% | | 2 | % | | | |
| | | | Loss severity | | 25% to 30% | | 26 | % | | | |
| | | | Discount rate/yield | | 11% to 16% | | 14 | % | | | | | Scenario analysis | | Estimated recovery percentage | | 2% to 41% | | 23 | % | | | | | | | | | | | | Residential mortgage-backed securities | | $ | 19,603 |
| | Discounted cash flows | | Cumulative loss rate | | 4% | | — |
| | | |
| | | | Duration (years) | | 13 years | | — |
| | | |
| | | | Discount rate/yield | | 3% | | — |
| | | | | | | Loss severity | | 0% | | — |
| | | | | Market approach | | Price | | $100 | | — |
| | | | | | | | | | | | Commercial mortgage-backed securities | | $ | 9,444 |
| | Discounted cash flows | | Cumulative loss rate | | 8% to 85% | | 45 | % | | | |
| | | | Duration (years) | | 1 year to 3 years | | 1 year | | | | | | | Discount rate/yield | | 2% to 15% | | 6 | % | | | | | | | Loss severity | | 64% | | — |
| | | | | Scenario analysis | | Estimated recovery percentage | | 26% | | — |
| | | | | | | Price | | $49 | | — |
| | | | | | | | | | | | Other asset-backed securities | | $ | 53,175 |
| | Discounted cash flows | | Cumulative loss rate | | 12% to 30% | | 22 | % | | | |
| | | | Duration (years) | | 1 year to 2 years | | 1 year | | | |
| | | | Discount rate/yield | | 6% to 12% | | 8 | % | | | | | Market approach | | Price | | $100 | | — |
| | | | | | | | | | | | Loans and other receivables | | $ | 46,078 |
| | Market approach | | Price | | $50 to $100 | | $96 | | | |
| | Scenario analysis | | Estimated recovery percentage | | 13% to 117% | | 105 | % | | | | | | | | | | | | Derivatives | | $ | 4,602 |
| | | | | | | | |
| Total return swaps | | |
| | Market approach | | Price | | $97 | | — |
| | | | | | | | | | | | Investments at fair value | | $ | 368,231 |
| | | | | | | | |
| Private equity securities | |
|
| | Market approach | | Price | | $3 to $250 | | $108 | | | | | | | Transaction level | | $169 | | — |
| | | | | Scenario analysis | | Discount rate/yield | | 20% | | — |
| | | | | | | Revenue growth | | 0% | | — |
| | | | | Contingent claims analysis | | Volatility | | 25% to 35% | | 30 | % | | | | | | | Duration (years) | | 4 years | | — |
| | | | | | | | | | | | Investment in FXCM | | $ | 73,150 |
| | | | | | | | |
| Term loan | |
|
| | Discounted cash flows | | Term based on the pay off (years) | | 0 months to 0.3 years | | 0.3 years | | | |
| | | | | | | | | Trading Liabilities | | | | | | | | | | | Loans | | $ | 6,376 |
| | Market approach | | Price | | $50 to $101 | | $74 | | | | | | | | | | | | Derivatives | | $ | 27,536 |
| | | | | | | | |
| Equity options | | |
| | Option model/default rate | | Default probability | | 0% | | — |
| | | | | Volatility benchmarking | | Volatility | | 39% to 62% | | 50 | % | Interest rate swaps | | | | Market approach | | Price | | $20 | | — |
| Total return swaps | | | | Market approach | | Price | | $97 | | — |
| | | | | | | | | | | | Long-term Debt | | $ | 200,745 |
| | | | | | | | | Structured notes | | | | Market approach | | Price | | $78 to $94 | | $86 | | | | | | | Price | | €68 to €110 | | €96 |
|
Summary Of Gains (Losses) Due To Changes In Instrument Specific Credit Risk For Loans and Other Receivables And Loan Commitments Measured At Fair Value Under Fair Value Option |
The following is a summary of Jefferies Group's gains (losses) due to changes in instrument specific credit risk on loans, other receivables and debt instruments and gains (losses) due to other changes in fair value on long-term debt measured at fair value under the fair value option (in thousands): | | | | | | | | | | | | | | | | | | For the Three Months Ended | | For the Nine Months Ended | | August 31, 2019 | | September 30, 2018 | | August 31, 2019 | | September 30, 2018 | Trading Assets: | | | | | | | | Loans and other receivables | $ | 2,040 |
| | $ | 14,002 |
| | $ | (5,458 | ) | | $ | 7,495 |
| | | | | | | | | Trading Liabilities: | |
| | |
| | |
| | |
| Loans | $ | — |
| | $ | (2,708 | ) | | $ | — |
| | $ | (2,467 | ) | Loan commitments | $ | (443 | ) | | $ | (1,695 | ) | | $ | (1,200 | ) | | $ | (1,964 | ) | | | | | | | | | Long-term Debt: | |
| | |
| | |
| | |
| Changes in instrument specific credit risk (1) | $ | 6,922 |
| | $ | 1,401 |
| | $ | 34,414 |
| | $ | 19,986 |
| Other changes in fair value (2) | $ | (46,003 | ) | | $ | (6,842 | ) | | $ | (93,311 | ) | | $ | 33,626 |
|
| | (1) | Changes in instrument specific credit risk related to structured notes are included in the Consolidated Statements of Comprehensive Income (Loss), net of tax. |
(2) Other changes in fair value are included in Principal transactions revenues in the Consolidated Statements of Operations
|
Summary Of Amount By Which Contractual Principal Exceeds Fair Value For Loans And Other Receivables Measured At Fair Value Under Fair Value Option |
The following is a summary of the amount by which contractual principal exceeds fair value for loans and other receivables and long-term debt measured at fair value under the fair value option (in thousands): | | | | | | | | | | August 31, 2019 | | November 30, 2018 | Trading Assets: | | | | Loans and other receivables (1) | $ | 1,356,508 |
| | $ | 961,554 |
| Loans and other receivables on nonaccrual status and/or 90 days or greater past due (1) (2) | $ | 139,795 |
| | $ | 158,392 |
| Long-term Debt | $ | 59,370 |
| | $ | 114,669 |
|
| | (1) | Interest income is recognized separately from other changes in fair value and is included in Interest income in the Consolidated Statements of Operations. |
(2) Amounts include all loans and other receivables 90 days or greater past due by which contractual principal exceeds fair value of $20.9 million and $20.5 million at August 31, 2019 and November 30, 2018, respectively
|